홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
SNDX
#1702
Syndax Pharmaceuticals, Inc.
21.7
1
+6.89%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+6.89%
월간 변동
+1.92%
6달 변화
+32.54%
년간 변동율
+43.02%
이전 종가
20.3
1
Open
21.7
1
Bid
Ask
Low
21.7
1
High
21.7
1
양
124
마켓
주식
헬스케어
SNDX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
뉴스
Stifel、医薬品売上を理由にSyndax Pharmaceuticalsの目標株価を引き上げ
Stifel raises Syndax Pharmaceuticals stock price target on drug sales
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2025 Earnings Call Transcript
Syndax 2025年第4四半期決算、売上高50%増、収益化への道筋を提示
Syndax Q4 2025 slides: revenue surges 50%, profitability path outlined
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
【決算速報】シンダックス・ファーマシューティカルズ、売上高は予想を上回り、利益は予想を下回る結果に
Syndax Pharmaceuticals earnings missed by $0.19, revenue topped estimates
がん治療薬の市場投入加速でSyndaxが決算試練に直面
Syndax faces earnings test as cancer drug launches accelerate
シンダックス、グッゲンハイム・サミットで力強い成長と戦略的拡大を発表
Syndax Pharmaceuticals' Early Launch Success Signals Continued Growth Into 2026 (NASDAQ:SNDX)